Post Marketing Information PEM 14/06/2023 SOLIRIS® (eculizumab) Physician’s guide: Paroxysmal Nocturnal Haemoglobinuria (PNH) and Atypical Haemolytic Uremic Syndrome (aHUS) PMG 14/06/2023 SOLIRIS® (eculizumab) Patient/Parent/Legal Guardian Guide: Paroxysmal Nocturnal Haemoglobinuria (PNH) and Atypical Haemolytic Uremic Syndrome (aHUS) PAC 14/06/2023 PATIENT SAFETY INFORMATION CARD: Important Safety Information for Patients Taking SOLIRIS® (eculizumab)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Soliris Infusion, Solution Concentrate 300 mg/vial National University Hospital